Related Experiment Video

Updated: Jul 11, 2026

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

[Pathogenesis of Parkinson disease]

Hiroki Takeuchi1, Ryosuke Takahashi

  • 1Graduate School of Medicine, Department of Neurology, Kyoto University, Japan.

Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
|September 15, 2007
PubMed

Insights

Parkinson disease (PD) pathogenesis involves environmental and genetic factors causing dopaminergic cell death. Oxidative stress and protein misfolding, particularly alpha-synuclein, are key mechanisms in both sporadic and familial forms.

Area of Science:

  • Neuroscience
  • Genetics
  • Environmental Health

Context:

  • Parkinson disease (PD) pathogenesis remains incompletely understood.
  • Dopaminergic cell death is a hallmark of PD.
  • Both environmental and genetic factors are implicated.

Purpose:

  • To review the current understanding of Parkinson disease pathogenesis.
  • To discuss the mechanisms underlying dopaminergic cell death in PD.
  • To explore factors contributing to both sporadic and familial PD.

Summary:

  • PD pathogenesis involves a complex interplay of environmental and genetic factors.
  • Oxidative stress, induced by agents like pesticides and dopamine derivatives, contributes to neurodegeneration.
  • Impairment of the ubiquitin-proteasome system and alpha-synuclein accumulation are critical in familial PD.

Impact:

  • Provides a comprehensive overview of PD pathogenic mechanisms.
  • Highlights key molecular and cellular pathways involved in neurodegeneration.
  • Informs future research directions for PD prevention and treatment.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.